← Open Payments lookup

KELLY KOEHLER: Open Payments

NPI 1003480179 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$587 in 25 payments from 5 companies in 2025. Trend: 2023 $377 · 2024 $143 · 2025 $587

Food & beverage: $587
CompanyPaymentsAmount
ABBVIE INC.9$223
Otsuka America Pharmaceutical, Inc.8$175
Alkermes, Inc.3$68
Novartis Pharmaceuticals Corporation3$63
E.R. Squibb & Sons, L.L.C.2$57

Products named: VRAYLAR, REXULTI, ARISTADA, LEQVIO, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, AVYCAZ.

Industry payments across NV — which companies pay providers there.